Trial intelligence / Profile preview

Amitriptyline versus CBT-I for chronic insomnia in adults with medical comorbidity

NL-OMON25122Not yet recruiting

Sponsor
Hospital Gelderse Vallei
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of amitriptyline in Insomnia (2 arms), sponsored by Hospital Gelderse Vallei. Primary endpoints: Insomnia Severity Index change, Treatment responder rate and 1 more. Planned start Sep 2019; status: not yet recruiting.

02

Drugs

amitriptyline
03

Conditions

Insomnia

Beyond the preview

Go deeper on NL-OMON25122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call